185 related articles for article (PubMed ID: 19329937)
1. Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil.
Selbst MK; Ahrens WA; Robert ME; Friedman A; Proctor DD; Jain D
Mod Pathol; 2009 Jun; 22(6):737-43. PubMed ID: 19329937
[TBL] [Abstract][Full Text] [Related]
2. Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern.
Papadimitriou JC; Cangro CB; Lustberg A; Khaled A; Nogueira J; Wiland A; Ramos E; Klassen DK; Drachenberg CB
Int J Surg Pathol; 2003 Oct; 11(4):295-302. PubMed ID: 14615824
[TBL] [Abstract][Full Text] [Related]
3. Histologic features in colon biopsies can discriminate mycophenolate from GVHD-induced colitis.
Star KV; Ho VT; Wang HH; Odze RD
Am J Surg Pathol; 2013 Sep; 37(9):1319-28. PubMed ID: 24076772
[TBL] [Abstract][Full Text] [Related]
4. Pointers and pitfalls of mycophenolate-associated colitis.
Lee S; de Boer WB; Subramaniam K; Kumarasinghe MP
J Clin Pathol; 2013 Jan; 66(1):8-11. PubMed ID: 23038687
[TBL] [Abstract][Full Text] [Related]
5. Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis.
Liapis G; Boletis J; Skalioti C; Bamias G; Tsimaratou K; Patsouris E; Delladetsima I
Histopathology; 2013 Nov; 63(5):649-58. PubMed ID: 24025088
[TBL] [Abstract][Full Text] [Related]
6. Unusually late-onset mycophenolate mofetil-related colitis.
Curtin BF; Rachakonda VP; Von Rosenvinge EC
Am J Health Syst Pharm; 2014 Nov; 71(21):1858-61. PubMed ID: 25320135
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes.
Parfitt JR; Jayakumar S; Driman DK
Am J Surg Pathol; 2008 Sep; 32(9):1367-72. PubMed ID: 18763324
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil-induced colitis in children.
Phatak UP; Seo-Mayer P; Jain D; Selbst M; Husain S; Pashankar DS
J Clin Gastroenterol; 2009; 43(10):967-9. PubMed ID: 19609219
[TBL] [Abstract][Full Text] [Related]
9. Patterns of injury in mycophenolate mofetil-related colitis.
Al-Absi AI; Cooke CR; Wall BM; Sylvestre P; Ismail MK; Mya M
Transplant Proc; 2010 Nov; 42(9):3591-3. PubMed ID: 21094821
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil-related pancolitis in a kidney transplant recipient.
Hamouda M; Mahmoudi H; Skhiri H; Elmay M
Exp Clin Transplant; 2012 Oct; 10(5):501-5. PubMed ID: 22554227
[TBL] [Abstract][Full Text] [Related]
11. Acute colonic pseudo-obstruction caused by mycophenolate mofetil in a kidney transplant recipient.
Almueilo SH; Alsulaiman RM
Exp Clin Transplant; 2015 Apr; 13(2):196-9. PubMed ID: 24918432
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil: a unique immunosuppressive agent.
Hood KA; Zarembski DG
Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil-induced colitis with graft versus host disease-like features in a liver transplant recipient.
Patra S; Vij M; Sukanya B; Kapoor D
Indian J Pathol Microbiol; 2012; 55(4):506-8. PubMed ID: 23455789
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-host disease-like features in mycophenolate mofetil-related colitis.
Papadimitriou JC; Drachenberg CB; Beskow CO; Cangro C; Wiland A; Klassen D; Weir M; Bartlett S
Transplant Proc; 2001 May; 33(3):2237-8. PubMed ID: 11377513
[No Abstract] [Full Text] [Related]
15. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
Chhabra D; Skaro AI; Leventhal JR; Dalal P; Shah G; Wang E; Gallon L
Clin J Am Soc Nephrol; 2012 Mar; 7(3):504-12. PubMed ID: 22282478
[TBL] [Abstract][Full Text] [Related]
16. Microscopic features associated with mycophenolate mofetil in gastric and colonic biopsies.
Coyne JD; Campbell F
Histopathology; 2012 Nov; 61(5):993-7. PubMed ID: 23106134
[No Abstract] [Full Text] [Related]
17. Orthotopic Heart Transplant Recipient with Enteric-coated Mycophenolate Sodium (Myfortic) Induced Colitis.
Morris CC; Stroud SC; Golconda U; Gregoire SA; Juneman EB
Am J Case Rep; 2020 May; 21():e920235. PubMed ID: 32404861
[TBL] [Abstract][Full Text] [Related]
18. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
Kirklin JK; Bourge RC; Naftel DC; Morrow WR; Deierhoi MH; Kauffman RS; White-Williams C; Nomberg RI; Holman WL; Smith DC
J Heart Lung Transplant; 1994; 13(3):444-50. PubMed ID: 8061021
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
Sollinger HW
Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
[TBL] [Abstract][Full Text] [Related]
20. Economic impact and long-term graft outcomes of mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant recipients.
Machnicki G; Ricci JF; Brennan DC; Schnitzler MA
Pharmacoeconomics; 2008; 26(11):951-67. PubMed ID: 18850764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
